Alconde, Netherlands

René Bernards

This inventor holds 1 USPTO granted patent. Top assignee: Topotarget UK Limited. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: René Bernards. Retrieved from https://idiyas.com/inventor/rené-bernards-y0wusapo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of René Bernards

Introduction

René Bernards is a notable inventor based in Alconde, Netherlands. He has made significant contributions to the field of molecular biology, particularly in understanding the interactions between proteins that play crucial roles in cell cycle regulation.

Latest Patents

One of his key patents is titled "Interaction between cyclin D1 and steroid receptor co-activators and uses thereof in assays." This invention reveals that cyclin D1 interacts in a ligand-independent manner with coactivators of the SRC-1 family. The direct interaction of cyclin D1 enhances estrogen receptor (ER) mediated transcription, providing a novel target for developing assays for substances that modulate the cell cycle. The invention outlines assay methods aimed at preventing tumor growth and identifying compounds useful in tumor prevention.

Career Highlights

René Bernards has been associated with Topotarget UK Limited, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of cancer biology and therapeutic development.

Collaborations

René has collaborated with several professionals in his field, including his coworker Renate M Zwijsen. Their joint efforts have led to advancements in the understanding of molecular interactions that are critical for cancer research.

Conclusion

René Bernards is a prominent figure in the field of molecular biology, with a focus on the interactions that influence cell cycle regulation. His innovative patent work continues to impact cancer research and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…